AUSTIN, Texas, July 2, 2025 /PRNewswire/ -- Between the fireworks, the forecast, and the family, July Fourth can feel like controlled chaos. But one...
Munich, Germany – July 2, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received Euro 2.3 million funding under the European Innovation Council (EIC) Accelerator program to advance its digital twin platform technology. In addition, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. The funding will support the market launch of Twinhale, the first in silico trial software built for pulmonary drug delivery. The investment also underpins Ebenbuild’s broader platform strategy to transform respiratory care through personalized lung simulation – from drug development to mechanical ventilation optimization in critical care.
PHOENIX, July 1, 2025 /PRNewswire/ -- Popular recipe website GiangisKitchen.com has shared a special selection of recipes for creating a fun and festive Independence...
Save up to 50% on summer favorites to fuel your festive plans, June 27–July 3, 2025
LAKEWOOD, Colo., June 26, 2025 /PRNewswire/ -- Natural Grocers®,...
Back on the USA TODAY’s 10Best ballot and ready to defend its title, Habit’s reigning #1 Double Char is just $1 at participating locations for a limited time
Back on the USA TODAY’s 10Best ballot and ready to defend its title, Habit’s reigning #1 Double Char is just $1 at participating locations for a limited time